Hector Guzman
About Hector Guzman
Hector Guzman serves as the Vice President of Technical Operations at Lyndra Therapeutics, where he has worked since 2022. He has extensive experience in process development, having held various leadership roles at Alkermes and TransForm Pharmaceuticals.
Work at Lyndra Therapeutics
Hector Guzman serves as the Vice President of Technical Operations at Lyndra Therapeutics, a role he has held since 2022. In this position, he focuses on the development of oral formulations, leveraging his extensive experience in process development. His leadership at Lyndra Therapeutics contributes to the company's mission of advancing innovative drug delivery systems. The company is located in Lexington, Massachusetts, where Guzman applies his expertise to enhance technical operations.
Previous Experience at Alkermes
Before joining Lyndra Therapeutics, Hector Guzman worked at Alkermes in various roles related to process development. He served as Executive Director of Process Development for four months in 2021, following a tenure as Sr. Director from 2019 to 2021. His career at Alkermes also included positions as Director, Associate Director, and Principal Engineer in Process Development, spanning over a decade. His roles involved leading teams and projects aimed at advancing drug formulation and manufacturing processes.
Education and Expertise
Hector Guzman holds a Bachelor of Science degree in Chemical Engineering from The Johns Hopkins University, where he studied from 1992 to 1996. He furthered his education by obtaining a Doctor of Philosophy (PhD) in Chemical Engineering from the Georgia Institute of Technology, completing his studies from 1996 to 2001. Guzman has developed expertise in small molecule preformulation, crystallization, and oral formulation, which he applies in his current and previous roles in the pharmaceutical industry.
Background in Formulation Development
Guzman's background includes significant experience in formulation development, particularly during his time at TransForm Pharmaceuticals, a Johnson & Johnson company. He worked as Principal Scientist in Formulation Development from 2001 to 2009. His work at TransForm Pharmaceuticals laid a foundation for his subsequent roles in process development at Alkermes, where he honed his skills in drug formulation and technical operations.